135 related articles for article (PubMed ID: 15875187)
41. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
42. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
[TBL] [Abstract][Full Text] [Related]
43. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
44. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
45. Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells.
Wan YF; Guo XQ; Wang ZH; Ying K; Yao MH
Acta Pharmacol Sin; 2004 Mar; 25(3):378-84. PubMed ID: 15000894
[TBL] [Abstract][Full Text] [Related]
46. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
Gu J; Yamamoto H; Lu X; Ngan CY; Tsujino T; Konishi K; Takemasa I; Ikeda M; Nagata H; Hashimoto S; Matsuzaki T; Sekimoto M; Takagi A; Monden M
Digestion; 2006; 74(1):19-27. PubMed ID: 16988507
[TBL] [Abstract][Full Text] [Related]
47. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
48. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.
Shang D; Ito N; Kamoto T; Ogawa O
Urology; 2007 May; 69(5):1007-12. PubMed ID: 17482960
[TBL] [Abstract][Full Text] [Related]
49. Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis.
Sui M; Fan W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1151-8. PubMed ID: 15752896
[TBL] [Abstract][Full Text] [Related]
50. Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro.
Mori T; Kinoshita Y; Watanabe A; Yamaguchi T; Hosokawa K; Honjo H
Cancer Chemother Pharmacol; 2006 Nov; 58(5):665-72. PubMed ID: 16534615
[TBL] [Abstract][Full Text] [Related]
51. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
52. Induction of apoptosis by paclitaxel in human oral carcinoma cells.
Nonaka M; Ikeda H; Fujisawa A; Uehara M; Inokuchi T
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):649-52. PubMed ID: 16513327
[TBL] [Abstract][Full Text] [Related]
53. The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.
Toiyama Y; Inoue Y; Hiro J; Ojima E; Watanabe H; Narita Y; Hosono A; Miki C; Kusunoki M
Cancer Chemother Pharmacol; 2007 May; 59(6):733-42. PubMed ID: 16957932
[TBL] [Abstract][Full Text] [Related]
54. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
AbouEl Hassan MA; Braam SR; Kruyt FA
Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
[TBL] [Abstract][Full Text] [Related]
56. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.
William-Faltaos S; Rouillard D; Lechat P; Bastian G
Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150
[TBL] [Abstract][Full Text] [Related]
57. Paclitaxel-induced apoptosis in osteosarcoma cell line U-2 OS.
Guo W; Zeng C; Dong F; Lei W
Chin Med J (Engl); 2002 Dec; 115(12):1796-801. PubMed ID: 12622926
[TBL] [Abstract][Full Text] [Related]
58. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.
Choi EJ; Kim T; Lee MS
Life Sci; 2007 Mar; 80(15):1403-8. PubMed ID: 17291540
[TBL] [Abstract][Full Text] [Related]
59. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
60. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
Mo Y; Lim LY
J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
